A contribution to the debate on tinnitus definition.


Journal

Progress in brain research
ISSN: 1875-7855
Titre abrégé: Prog Brain Res
Pays: Netherlands
ID NLM: 0376441

Informations de publication

Date de publication:
2021
Historique:
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 25 11 2021
Statut: ppublish

Résumé

Tinnitus is generally defined as an auditory perception in the absence of environmental sound stimulation. However, this definition is quite incomplete as it omits an essential aspect, the patient's point of view. This point of view constitutes, first and foremost, a global and unified lived experience, which is not only sensory (localization, loudness, pitch and tone), but also cognitive (thoughts, attentiveness, behaviors) and emotional (discomfort, suffering). This experience can be lived in a very unpleasant way and consequently have a very negative impact on quality of life. This article proposes and justifies a new definition for tinnitus elaborated by a group of French clinicians and researchers, which is more in line with its phenomenology. It also provides a minimum knowledge base, including possibilities for clinical care, hoping to eradicate all misinformation, misconceptions and inappropriate attitudes or practices toward this condition. Here is the short version of our definition: Tinnitus is an auditory sensation without an external sound stimulation or meaning, which can be lived as an unpleasant experience, possibly impacting quality of life.

Identifiants

pubmed: 33931192
pii: S0079-6123(21)00029-7
doi: 10.1016/bs.pbr.2021.01.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

469-485

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Arnaud J Noreña (AJ)

Laboratoire de Neurosciences Cognitives, UMR 7291, Centre National de la Recherche Scientifique, Aix-Marseille University, Marseille, France. Electronic address: arnaud.norena@univ-amu.fr.

Stéphane Lacher-Fougère (S)

Centre médical, Bordeaux, France.

Marie-José Fraysse (MJ)

Hopital de Purpan, Toulouse, France.

Eric Bizaguet (E)

Laboratoire de Correction Auditive, Paris, France.

Patricia Grevin (P)

Paris, France.

Hung Thai-Van (H)

Hôpital Edouard Herriot, Pavillon U, Place d'Arsonval, Lyon, France.

Livia Moati (L)

AERA, Paris, France.

Christine Le Pajolec (C)

Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Philippe Fournier (P)

Laboratoire de Neurosciences Cognitives, UMR 7291, Centre National de la Recherche Scientifique, Aix-Marseille University, Marseille, France.

Martine Ohresser (M)

Centre Medical, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH